-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Should I Buy Pfizer? 3 Pros, 3 Cons
Pfizer's Q4 earnings put a small scare into investors a couple weeks back, but the pharma behemoth is built too well to ignore.
Stock Gets Big Boost on Angelina Jolie’s Double Mastectomy Announcement
In the wake of Angelina Jolie's announcement, the company that makes the test she used is enjoying a nice bump in its stock price.
Don’t Fear the Fed — Buy Income on the Dip
The next pullback is around the corner; use that as a chance to buy these 3 income stocks.
3 Hot Biotechs to Keep on Your Radar
The key to successfully investing in these biotechs is being able to sort the winners from the losers. Here are three picks that get a thumbs-up.
Belviq Is Not the Next Fen-Phen … Probably
Arena Pharmaceuticals' withdrawal of its European application for Belviq has turned the stock into a three-ring circus. Don't panic -- just get the facts straight.
Pfizer Spares Patients From Erectile Dysfunction Embarrassment
Pfizer has created an industry first by selling its successful Viagra pill directly to consumers -- a move that has implications for major drugmakers and pharmacies alike.
Viagra About to Be Available Online
Drugmaker Pfizer is taking Viagra online and selling it directly to patients on its own website.
Ride This Biotech’s Powerful Bull Trend
Illumina jumped to a 20-month high and is under heavy accumulation.
Take the Money and Run in This Biotech
Following two FDA rejections and two sell signals, it's time to cash out of Gilead Sciences.
3 Pharma Stocks to Buy Into Earnings
We'll learn a lot about healthcare names over the course of this earnings season -- I'm expecting big things from these three drugmakers.
For Health Insurers Investors, Uncertainty Equals Opportunity
Investors are getting mixed signals from health insurers over the Affordable Care Act. Use uncertainty to your advantage by buying their stocks on pullbacks.
Tech, Banks Continue to Slide — Thursday’s IP Market Recap
Markets fell broadly for a second straight day on the heels of unimpressive earnings reports, and a selloff in tech and bank stocks
Monday’s Mega-Deals: U.S. M&A Is Back
Dish Network's bid for Sprint and Thermo Fisher's deal with Life Technologies continue a run for U.S. M&A that should hopefully keep the cycle of market confidence rolling.
Healthcare Stocks: The Market’s Latest Untouchable Sector
The healthcare sector has delivered outstanding year-to-date returns, but investors need to be aware how much of the performance is the result of macro trends.
Acadia Booms, But Has a Long Way to Go
ACADIA Pharmaceuticals rocketed to 64% gains yesterday on good news regarding its Parkinson's disease treatment ... but let's not put the cart before the horse.
Bulls vs. Bears: Can Biogen Keep Booming?
Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments.
Hospital Stocks Might Be in a Holding Pattern
Things were going so well for hospital stocks before Wednesday, when they hit a wall. The question going forward: What's over that wall?
Acquire This Biotech Takeover Target ASAP
Life Technologies is rumored to be looking for a buyer, and the stock is poised for a breakout.
